Medicure Statistics
Total Valuation
Medicure has a market cap or net worth of 6.48 million. The enterprise value is 1.97 million.
| Market Cap | 6.48M |
| Enterprise Value | 1.97M |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 10.44M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 5.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | 0.45 |
| P/TBV Ratio | 1.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 6.78 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.73 |
| EV / Sales | 0.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.89 |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -66.76 |
Financial Efficiency
Return on equity (ROE) is -5.11% and return on invested capital (ROIC) is -8.13%.
| Return on Equity (ROE) | -5.11% |
| Return on Assets (ROA) | -5.93% |
| Return on Invested Capital (ROIC) | -8.13% |
| Return on Capital Employed (ROCE) | -12.86% |
| Revenue Per Employee | 400,670 |
| Profits Per Employee | -19,003 |
| Employee Count | 38 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 2.85 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.21% in the last 52 weeks. The beta is 0.69, so Medicure's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -25.21% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 0.84 |
| Relative Strength Index (RSI) | 56.75 |
| Average Volume (20 Days) | 3,776 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicure had revenue of 15.23 million and -722,109 in losses. Loss per share was -0.07.
| Revenue | 15.23M |
| Gross Profit | 9.10M |
| Operating Income | -1.90M |
| Pretax Income | -544,188 |
| Net Income | -722,109 |
| EBITDA | -704,734 |
| EBIT | -1.90M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 5.00 million in cash and 607,434 in debt, giving a net cash position of 4.39 million.
| Cash & Cash Equivalents | 5.00M |
| Total Debt | 607,434 |
| Net Cash | 4.39M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 14.44M |
| Book Value Per Share | 1.38 |
| Working Capital | 5.21M |
Cash Flow
| Operating Cash Flow | 957,021 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 59.75%, with operating and profit margins of -12.49% and -4.74%.
| Gross Margin | 59.75% |
| Operating Margin | -12.49% |
| Pretax Margin | -3.57% |
| Profit Margin | -4.74% |
| EBITDA Margin | -4.63% |
| EBIT Margin | -12.49% |
| FCF Margin | n/a |
Dividends & Yields
Medicure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -11.14% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 2, 2012. It was a reverse split with a ratio of 0.0666666.
| Last Split Date | Nov 2, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.0666666 |
Scores
Medicure has an Altman Z-Score of -1.66. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.66 |
| Piotroski F-Score | n/a |